Related Experiment Videos
[Continous ambulatory peritoneal dialysis (CAPD)].
Schweizerische Medizinische Wochenschrift
|December 29, 1979
Summary
Continuous ambulatory peritoneal dialysis (CAPD) effectively manages uremia but has a high peritonitis rate. Technical improvements are needed before widespread CAPD adoption can be recommended.
Area of Science:
- Nephrology
- Internal Medicine
Context:
- Continuous ambulatory peritoneal dialysis (CAPD) is an emerging renal replacement therapy.
- Previous intermittent peritoneal dialysis (IPD) had limitations in managing uremia, hypertension, and phosphate levels.
Purpose:
- To evaluate the efficacy and complications of CAPD in patients with end-stage renal disease.
Summary:
- CAPD provided adequate clinical and biochemical control of uremia in eleven patients over 48 patient-months.
- Hypertension and serum phosphate levels were easier to manage with CAPD compared to IPD.
- The study observed a mean protein loss of 9.7 g/day and a high incidence of peritonitis (1 episode per 6.8 months) in 3 patients.
- Elevated triglyceride levels were noted as a potential complication in 4 patients.
Impact:
- CAPD demonstrates potential for effective uremic management but requires significant technical improvements to reduce peritonitis rates before general recommendation.
- Further research into mitigating CAPD-related complications like hypertriglyceridemia is warranted.